These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10947948)

  • 21. Autophosphorylation kinetics of protein kinases.
    Wang ZX; Wu JW
    Biochem J; 2002 Dec; 368(Pt 3):947-52. PubMed ID: 12190618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Class IA Phosphatidylinositol 3-Kinase Isoform p110α Mediates Vascular Remodeling.
    Vantler M; Jesus J; Leppänen O; Scherner M; Berghausen EM; Mustafov L; Chen X; Kramer T; Zierden M; Gerhardt M; Ten Freyhaus H; Blaschke F; Sterner-Kock A; Baldus S; Zhao JJ; Rosenkranz S
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1434-44. PubMed ID: 25908763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of semi-synthesized quercetin water-soluble derivatives on recombinant human phosphatidylinositol 3-kinase p110beta catalytic subunit.
    Liu W; Liang NC
    Acta Pharmacol Sin; 2002 Apr; 23(4):339-42. PubMed ID: 11931710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of the insulin receptor beta-subunit with phosphatidylinositol 3-kinase in bovine ROS.
    Rajala RV; Anderson RE
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3110-7. PubMed ID: 11726610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo functional analysis of the counterbalance of hyperactive phosphatidylinositol 3-kinase p110 catalytic oncoproteins by the tumor suppressor PTEN.
    Andrés-Pons A; Rodríguez-Escudero I; Gil A; Blanco A; Vega A; Molina M; Pulido R; Cid VJ
    Cancer Res; 2007 Oct; 67(20):9731-9. PubMed ID: 17942903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of three flavones on enzyme activity of recombinant human phosphoinositide 3-kinase p110beta catalytic subunit].
    Liu W; Liang NC; Huang RB
    Zhong Yao Cai; 2006 Jan; 29(1):33-6. PubMed ID: 16722316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A biochemical mechanism for the oncogenic potential of the p110beta catalytic subunit of phosphoinositide 3-kinase.
    Dbouk HA; Pang H; Fiser A; Backer JM
    Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19897-902. PubMed ID: 21030680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterodimeric phosphoinositide 3-kinase consisting of p85 and p110beta is synergistically activated by the betagamma subunits of G proteins and phosphotyrosyl peptide.
    Kurosu H; Maehama T; Okada T; Yamamoto T; Hoshino S; Fukui Y; Ui M; Hazeki O; Katada T
    J Biol Chem; 1997 Sep; 272(39):24252-6. PubMed ID: 9305878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Over-expression of the p110beta but not p110alpha isoform of PI 3-kinase inhibits motility in breast cancer cells.
    Yip SC; El-Sibai M; Hill KM; Wu H; Fu Z; Condeelis JS; Backer JM
    Cell Motil Cytoskeleton; 2004 Nov; 59(3):180-8. PubMed ID: 15468162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamics of GFP-Fusion p110α and p110β Isoforms of PI3K Signaling Pathway in Normal and Cancer Cells.
    Singh P; Dar MS; Singh G; Jamwal G; Sharma PR; Ahmad M; Dar MJ
    J Cell Biochem; 2016 Dec; 117(12):2864-2874. PubMed ID: 27167447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid kinase and protein kinase activities of G-protein-coupled phosphoinositide 3-kinase gamma: structure-activity analysis and interactions with wortmannin.
    Stoyanova S; Bulgarelli-Leva G; Kirsch C; Hanck T; Klinger R; Wetzker R; Wymann MP
    Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):489-95. PubMed ID: 9182708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct and opposing roles for the phosphatidylinositol 3-OH kinase catalytic subunits p110α and p110β in the regulation of insulin secretion from rodent and human beta cells.
    Kolic J; Spigelman AF; Plummer G; Leung E; Hajmrle C; Kin T; Shapiro AM; Manning Fox JE; MacDonald PE
    Diabetologia; 2013 Jun; 56(6):1339-49. PubMed ID: 23568272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth.
    Leevers SJ; Weinkove D; MacDougall LK; Hafen E; Waterfield MD
    EMBO J; 1996 Dec; 15(23):6584-94. PubMed ID: 8978685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A high-throughput liposome substrate assay with automated lipid extraction process for PI 3-kinase.
    Lingaraj T; Donovan J; Li Z; Li P; Doucette A; Harrison S; Ecsedy JA; Dang L; Zhang W
    J Biomol Screen; 2008 Oct; 13(9):906-11. PubMed ID: 18812570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic mutations of p110α isoform of PI 3-kinase upregulate its protein kinase activity.
    Buchanan CM; Dickson JM; Lee WJ; Guthridge MA; Kendall JD; Shepherd PR
    PLoS One; 2013; 8(8):e71337. PubMed ID: 23936502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the expression patterns of class I PI3K catalytic subunits and its prognostic significance in colorectal cancer.
    Cui B; Tao J; Yang Y
    Cell Biochem Biophys; 2012 Jan; 62(1):47-54. PubMed ID: 21910030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Class I phosphoinositide 3-kinase p110beta is required for apoptotic cell and Fcgamma receptor-mediated phagocytosis by macrophages.
    Leverrier Y; Okkenhaug K; Sawyer C; Bilancio A; Vanhaesebroeck B; Ridley AJ
    J Biol Chem; 2003 Oct; 278(40):38437-42. PubMed ID: 12869549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphoinositide 3-kinases p110alpha and p110beta regulate cell cycle entry, exhibiting distinct activation kinetics in G1 phase.
    Marqués M; Kumar A; Cortés I; Gonzalez-García A; Hernández C; Moreno-Ortiz MC; Carrera AC
    Mol Cell Biol; 2008 Apr; 28(8):2803-14. PubMed ID: 18285463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells.
    Zhao JJ; Liu Z; Wang L; Shin E; Loda MF; Roberts TM
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18443-8. PubMed ID: 16339315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation loop sequences confer substrate specificity to phosphoinositide 3-kinase alpha (PI3Kalpha ). Functions of lipid kinase-deficient PI3Kalpha in signaling.
    Pirola L; Zvelebil MJ; Bulgarelli-Leva G; Van Obberghen E; Waterfield MD; Wymann MP
    J Biol Chem; 2001 Jun; 276(24):21544-54. PubMed ID: 11278889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.